Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,576
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Location: New York NY, Manhasset NY, New Brunswick NJ, Hamden CT,
Sponsor: Vedanta Biosciences, Inc.
Sex: All
Age: 12+
Code: NCT06237452
Phase 3, Recruiting
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: New York NY, Mineola NY, Stony Brook NY, Camden NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06380751
Phase 3, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: New York NY, Eatontown NJ, Langhorne PA, Media PA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
I-DECIDE After Bronchiolitis Hospitalization
for
Bronchiolitis Acute
Location: New York NY, Hackensack NJ, The Bronx NY,
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0 - 2
Code: NCT07243652
Recruiting
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
Location: New York NY, Newark NJ, Hackensack NJ, The Bronx NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT06368817
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: New York NY, Hackensack NJ, Mineola NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase 3, Recruiting
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: New York NY, Brooklyn NY, The Bronx NY, Mineola NY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06500481
Phase 3, Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: New York NY, Newark NJ, Hackensack NJ, New Hyde Park NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase 3, Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: New York NY, The Bronx NY, Mineola NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase 3, Recruiting
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
for
Astrocytoma, IDH-Mutant, Grade 3
Location: New York NY, Brooklyn NY, Hackensack NJ, Summit NJ,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 12+
Code: NCT07215910
Phase 3, Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
for
Recurrent Glioblastoma, IDH-Wildtype,
Location: New York NY, Newark NJ, Livingston NJ, New Brunswick NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05432804
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: New York NY, Morristown NJ, Mineola NY, Montvale NJ,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07409272
Phase 3, Recruiting
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
for
Gastric Adenocarcinoma,
Location: New York NY, Mineola NY, Montvale NJ, Uniondale NY,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT07001748
Phase 2, Phase 3, Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
for
Buccal Mucosa Squamous Cell Carcinoma,
Location: New York NY, Livingston NJ, Mineola NY, Montvale NJ,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT04333537
Phase 2, Phase 3, Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Location: New York NY, Brooklyn NY, The Bronx NY, Mineola NY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06958328
Phase 3, Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: New York NY, Brooklyn NY, Newark NJ, Hackensack NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase 2, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: New York NY, Hackensack NJ, The Bronx NY, Paterson NJ,